Early Stage Devices For Rare Conditions Receive FDA Funding
This article was originally published in The Gray Sheet
Executive Summary
An early intervention to treat scoliosis and a test for diagnosing eosinophilic esophagitis were among the innovations FDA supported Oct. 21, when it announced the recipients of 15 grants worth more than $14 million and focused on rare disease treatment.